Bioorganic and Medicinal Chemistry Letters p. 3583 - 3588 (1998)
Update date:2022-08-03
Topics:
Ambler, John
Baker, Emma
Brown, Lyndon
Butler, Paul
Farr, Dave
Dunnet, Karen
Le Grand, Darren
Janus, Diana
Jones, Darryl
Menear, Keith
Mercer, Mark
Smith, Garrick
Talbot, Mark
Tweed, Morris
The chemical optimisation of CGH1668 1 is described employing an in vivo model of absorption to determine the influence on bioavailability of single point modifications to five key molecular templates. The discovery of an orally bioavailable and selective thrombin inhibitor, 24, highlights the utility of this approach.
View MoreContact:86-898-65311214
Address:Room 102, BLDG. 68 Jiangnan City, No. 66 Heping Road,Haikou, Hainan, China
Jiaozuo Zhongwen Trading Coporation Limited
Contact:+86 0391-3553810
Address:East Renmin Road
Sinoway International (Jiangsu) Co., Ltd.
Contact:+86-25-86630167
Address:17 Beijing Road (West), Nanjing, China
Hebei Tianxiang Biological & Pharmaceutical Co., Ltd
Contact:86-0312-6615158
Address:No 42 fazhan street qingyuan county
xi'an taima biological engineering co., ltd.
Contact:+8615619038117
Address:6 No,keji road xi'an city of china
Doi:10.1016/j.tet.2010.05.054
(2010)Doi:10.1039/a705571d
(1997)Doi:10.1007/BF02291796
(1997)Doi:10.1021/jm00301a034
(1969)Doi:10.1039/DT9950002923
(1995)Doi:10.1021/jo060129c
(2006)